CEACAM5 and neoplasm: The discovery of the inhibitory role of CEACAM5+ tumour cells in the innate immune cells increases emphasis on harnessing innate immunity in immunotherapy, particularly when most of the current immunomodulatory approaches have focused on unleashing effector T cells.